[68Ga]Ga-iPSMA-Lys3-Bombesin: Biokinetics, dosimetry and first patient PET/CT imaging-Reference-Cited by-同舟云学术

[68Ga]Ga-iPSMA-Lys3-Bombesin: Biokinetics, dosimetry and first patient PET/CT imaging

Published:2021-05 Issue: Volume:96-97 Page:54-60
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Rivera-Bravo Belén,Ramírez-Nava Gerardo,Mendoza-Figueroa Mónica J.,Ocampo-García Blanca,Ferro-Flores Guillermina,Ávila-Rodríguez Miguel A.,Santos-Cuevas Clara

Funder

Consejo Nacional de Ciencia y Tecnologia

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference29 articles.

1. Current state of radiolabeled heterobivalent peptidic ligands in tumor imaging and therapy;Judmann;Pharmaceuticals,2020

2. Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer;Bandari;Nucl Med Biol,2014

3. Heterodimeric radiotracer targeting PSMA and GRPR for imaging of prostate cancer-optimization of the affinity towards PSMA by linker modification in murine model;Lundmark;Pharmaceutics,2020

4. Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer;Eder;Prostate,2014

5. Design, synthesis and in vitro evaluation of heterobivalent peptidic radioligands targeting both GRP- and VPAC 1-receptors concomitantly overexpressed on various malignancies - is the concept feasible?;Lindner;Eur J Med Chem,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiopharmaceuticals Targeting Gastrin-Releasing Peptide Receptor for Diagnosis and Therapy of Prostate Cancer;Molecular Pharmaceutics;2024-08-06

2. Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management;PET Clinics;2024-07

3. Elevating theranostics: The emergence and promise of radiopharmaceutical cell‐targeting heterodimers in human cancers;iRADIOLOGY;2024-04

4. Application of targeted diagnosis of PSMA in the modality shift of prostate cancer diagnosis: a review;Frontiers in Oncology;2023-09-01

5. A prospective comparative study of [68Ga]Ga-RM26 and [68Ga]Ga-PSMA-617 PET/CT imaging in suspicious prostate cancer;European Journal of Nuclear Medicine and Molecular Imaging;2023-02-22